Endogenous ATP involvement in mustard-oil-induced central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn)

被引:48
作者
Chiang, CY
Zhang, S
Xie, YF
Hu, JW
Dostrovsky, JO
Salter, MW
Sessle, BJ
机构
[1] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada
[2] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada
[3] Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.1152/jn.00223.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Central sensitization represents a sustained hypersensitive state of dorsal horn nociceptive neurons that can be evoked by peripheral inflammation or injury to nerves and tissues. It reflects neuroplastic changes such as increases in neuronal spontaneous activity, receptive field size, and responses to suprathreshold stimuli and a decrease in activation threshold. We recently demonstrated that purinergic receptor mechanisms in trigeminal subnucleus caudalis (Vc; medullary dorsal horn) are also involved in the initiation and maintenance of central sensitization in brain stem nociceptive neurons of trigeminal subnucleus oralis. The aim of the present study was to investigate whether endogenous ATP is involved in the development of central sensitization in Vc itself. The experiments were carried out on urethan/alpha-chloralose anesthetized and immobilized rats. Single neurons were recorded and identified as nociceptive-specific (NS) in the deep laminae of Vc. During continuous saline superfusion (0.6 ml/h it) over the caudal medulla, Vc neuronal central sensitization was readily induced by mustard oil application to the tooth pulp. However, this mustard-oil-induced central sensitization could be completely blocked by continuous intrathecal superfusion of the wide-spectrum P2X receptor antagonist pyridoxal-phosphate-6-azophenyl-2, 4-disulphonic acid tetra-sodium (33-100 mu M) and by apyrase (an ectonucleotidase enzyme, 30 units/ml). Superfusion of the selective P2X(1), P2X(3) and P2X(2/3) receptor antagonist 2', 3'- O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (6-638 mu M) partially blocked the Vc central sensitization. The two P2X receptor antagonists did not significantly affect the baseline nociceptive properties of the Vc neurons. These findings implicate endogenous ATP as an important mediator contributing to the development of central sensitization in nociceptive neurons of the deep laminae of the dorsal horn.
引用
收藏
页码:1751 / 1760
页数:10
相关论文
共 66 条
[1]   A P2X PURINOCEPTOR CDNA CONFERRING A NOVEL PHARMACOLOGICAL PROFILE [J].
BO, XN ;
ZHANG, Y ;
NASSAR, M ;
BURNSTOCK, G ;
SCHOEPFER, R .
FEBS LETTERS, 1995, 375 (1-2) :129-133
[2]   An antagonist-insensitive P-2X receptor expressed in epithelia and brain [J].
Buell, G ;
Lewis, C ;
Collo, G ;
North, RA ;
Surprenant, A .
EMBO JOURNAL, 1996, 15 (01) :55-62
[3]   Competitive antagonism of recombinant P2X2/3 receptors by 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP) [J].
Burgard, EC ;
Niforatos, W ;
Van Biesen, T ;
Lynch, KJ ;
Kage, KL ;
Touma, E ;
Kowaluk, EA ;
Jarvis, MF .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1502-1510
[4]   P2X receptors in sensory neurones [J].
Burnstock, G .
BRITISH JOURNAL OF ANAESTHESIA, 2000, 84 (04) :476-488
[5]   PARABRACHIAL AREA AND NUCLEUS RAPHE MAGNUS-INDUCED MODULATION OF NOCICEPTIVE AND NONNOCICEPTIVE TRIGEMINAL SUBNUCLEUS CAUDALIS NEURONS ACTIVATED BY CUTANEOUS OR DEEP INPUTS [J].
CHIANG, CY ;
HU, JW ;
SESSLE, BJ .
JOURNAL OF NEUROPHYSIOLOGY, 1994, 71 (06) :2430-2445
[6]   NMDA receptor mechanisms contribute to neuroplasticity induced in caudalis nociceptive neurons by tooth pulp stimulation [J].
Chiang, CY ;
Park, SJ ;
Kwan, CL ;
Hu, JW ;
Sessle, BJ .
JOURNAL OF NEUROPHYSIOLOGY, 1998, 80 (05) :2621-2631
[7]  
Chiang CY, 2003, PROG PAIN RES MANAG, V24, P345
[8]   Central sensitization of nociceptive neurons in trigeminal subnucleus oralis depends on integrity of subnucleus caudalis [J].
Chiang, CY ;
Hu, B ;
Hu, JW ;
Dostrovsky, JO ;
Sessle, BJ .
JOURNAL OF NEUROPHYSIOLOGY, 2002, 88 (01) :256-264
[9]  
CHIANG CY, 2003, SOC NEUR ABSTR, V29
[10]  
Chizh BA, 2001, PHARMACOL REV, V53, P553